Enoxaparin sodium improves pregnancy outcome in aspirin-resistant antiphospholipid/antiprotein antibody syndromes

Thrombosis and Haemostasis

Volumn 87, Issue 3, 2002, Pages 536-537

  Gris, Jean Christophe ^a   Balducchi, Jean Pierre ^a   Quére, Isabelle ^a   Hoffet, Méderic ^a   Marès, Pierre ^a  

^a NÎMES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA2 GLYCOPROTEIN 1; CALPHOBINDIN II; ENOXAPARIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID ANTIBODY; ANTICOAGULANT AGENT;

ANTIPHOSPHOLIPID SYNDROME; CESAREAN SECTION; CHILDBIRTH; CLINICAL TRIAL; CONFIDENCE INTERVAL; DELIVERY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FETUS WASTAGE; FOLLOW UP; GESTATION PERIOD; HUMAN; LETTER; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MONOTHERAPY; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; SPONTANEOUS ABORTION; THIRD TRIMESTER PREGNANCY; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOPHILIA; COMPARATIVE STUDY; DRUG RESISTANCE; PREGNANCY OUTCOME; RECURRENT ABORTION;

ABORTION, HABITUAL; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; DRUG RESISTANCE; ENOXAPARIN; FEMALE; HUMANS; PREGNANCY; PREGNANCY OUTCOME;

EID: 0036125778     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613036     Document Type: Letter

References (7)

1. Antiphopholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone
2. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
3. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled study
4. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin
5. Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. NOHA4
6. Changes in the pharmacokinetics of the low-molecular weight heparin enoxaparin sodium during pregnancy
7. The Enoxaparin Clinical Trial Group. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease